In This Article:
Amid a backdrop of mixed global economic signals, with the Hang Seng Index showing resilience by rising 1.59%, investors in Hong Kong are increasingly focusing on growth companies that exhibit high insider ownership. Such stocks often suggest a commitment from management and major stakeholders to the company's long-term success, which can be particularly appealing in uncertain market conditions.
Top 10 Growth Companies With High Insider Ownership In Hong Kong
Name | Insider Ownership | Earnings Growth |
iDreamSky Technology Holdings (SEHK:1119) | 20.1% | 104.1% |
New Horizon Health (SEHK:6606) | 16.6% | 62.3% |
Meitu (SEHK:1357) | 38% | 33.7% |
DPC Dash (SEHK:1405) | 38.2% | 89.7% |
Zylox-Tonbridge Medical Technology (SEHK:2190) | 18.5% | 79.3% |
Adicon Holdings (SEHK:9860) | 22.3% | 29.6% |
Tian Tu Capital (SEHK:1973) | 34% | 70.5% |
Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 13.9% | 100.1% |
Zhejiang Leapmotor Technology (SEHK:9863) | 15% | 73.8% |
Beijing Airdoc Technology (SEHK:2251) | 27.8% | 83.9% |
Underneath we present a selection of stocks filtered out by our screen.
BYD
Simply Wall St Growth Rating: ★★★★☆☆
Overview: BYD Company Limited operates in the automotive and battery sectors across China, Hong Kong, Macau, Taiwan, and globally, with a market capitalization of approximately HK$708.77 billion.
Operations: The company generates revenue primarily from its automotive and battery sectors.
Insider Ownership: 30.1%
BYD, a growth company with significant insider ownership in Hong Kong, recently approved amendments to its bylaws and declared a dividend of RMB 3.096 per share. The firm reported substantial year-over-year increases in monthly and annual production and sales volumes, indicating robust operational growth. Additionally, BYD's launch of the SHARK pickup in Mexico marks its first global product introduction outside China, potentially expanding its market footprint. These developments suggest a positive outlook, aligning with forecasts that BYD's earnings will grow faster than the Hong Kong market average.
-
Delve into the full analysis future growth report here for a deeper understanding of BYD.
-
Our valuation report unveils the possibility BYD's shares may be trading at a premium.
Alibaba Health Information Technology
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Alibaba Health Information Technology Limited operates in pharmaceutical direct sales, e-commerce platforms, and healthcare digital services in Mainland China and Hong Kong, with a market capitalization of approximately HK$62.07 billion.